The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation
出版年份 2018 全文链接
标题
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation
作者
关键词
-
出版物
Cancer Medicine
Volume 7, Issue 7, Pages 3257-3268
出版商
Wiley
发表日期
2018-05-15
DOI
10.1002/cam4.1543
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6
- (2017) Miki Furukawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma
- (2017) Bernhard Gillissen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural history of t(11;14) multiple myeloma
- (2017) A Lakshman et al. LEUKEMIA
- Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells
- (2016) Pasupathi Sundaramoorthy et al. Acta Biomaterialia
- Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
- (2016) E. A. Punnoose et al. MOLECULAR CANCER THERAPEUTICS
- Novel self-micellizing anticancer lipid nanoparticles induce cell death of colorectal cancer cells
- (2015) Pasupathi Sundaramoorthy et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Dexamethasone treatment promotes Bcl-2 dependence in multiple myeloma resulting in sensitivity to venetoclax
- (2015) S M Matulis et al. LEUKEMIA
- Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax
- (2015) R Bajpai et al. ONCOGENE
- MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
- (2015) G S Choudhary et al. Cell Death & Disease
- Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma
- (2014) J. Kummetha Venkata et al. BLOOD
- ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia
- (2013) C. J. Vandenberg et al. BLOOD
- The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
- (2013) C Touzeau et al. LEUKEMIA
- t(11;14) multiple myeloma: A subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome
- (2013) Gang An et al. LEUKEMIA RESEARCH
- Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Bortezomib and Hypoxia-Activated Prodrug TH-302, In Vivo and In Vitro
- (2013) J. Hu et al. MOLECULAR CANCER THERAPEUTICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Editorial [Hot Topic: Therapeutic Targeting of the Sphingolipid “Biostat” in Hematologic Malignancies (Guest Editors: Thomas P. Loughran and Hong-Gang Wang)]
- (2012) Thomas P. Loughran et al. Anti-Cancer Agents in Medicinal Chemistry
- MYC addiction: a potential therapeutic target in MM
- (2012) W. M. Kuehl et al. BLOOD
- Lipid metabolism in cancer
- (2012) Claudio R. Santos et al. FEBS Journal
- Sphingolipids in cancer
- (2011) Hideki Furuya et al. CANCER AND METASTASIS REVIEWS
- β-Lapachone Significantly Increases the Effect of Ionizing Radiation to Cause Mitochondrial Apoptosis via JNK Activation in Cancer Cells
- (2011) Moon-Taek Park et al. PLoS One
- S1P metabolism in cancer and other pathological conditions
- (2010) Weng In Leong et al. BIOCHIMIE
- Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation
- (2010) Ashley J. Snider et al. BIOCHIMIE
- A study design to investigate the effect of short-form Sun-style Tai Chi in improving functional exercise capacity, physical performance, balance and health related quality of life in people with Chronic Obstructive Pulmonary Disease (COPD)
- (2010) R.W.M. Leung et al. Contemporary Clinical Trials
- Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance
- (2010) Suriyan Ponnusamy et al. Future Oncology
- Therapeutic applications of bioactive sphingolipids in hematological malignancies
- (2010) Huseyin Atakan Ekiz et al. INTERNATIONAL JOURNAL OF CANCER
- Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Inhibition of Notch Signaling and Bcl-2/Bcl-xL Results in Synergistic Antimyeloma Effect
- (2010) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Sphingolipids in inflammation: pathological implications and potential therapeutic targets
- (2009) Graeme F. Nixon BRITISH JOURNAL OF PHARMACOLOGY
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling
- (2008) Michael Maceyka et al. JOURNAL OF LIPID RESEARCH
- Caspase-2 Cleavage of BID Is a Critical Apoptotic Signal Downstream of Endoplasmic Reticulum Stress
- (2008) J.-P. Upton et al. MOLECULAR AND CELLULAR BIOLOGY
- Sphingolipids: players in the pathology of metabolic disease
- (2008) L. Ashley Cowart TRENDS IN ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now